Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(1.98)
# 2,801
Out of 4,829 analysts
470
Total ratings
34.12%
Success rate
-8.97%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCGN Ocugen | Maintains: Buy | $8 → $7 | $0.67 | +944.78% | 21 | May 12, 2025 | |
| VOR Vor Biopharma | Downgrades: Neutral | n/a | $0.15 | - | 12 | May 9, 2025 | |
| ALXO ALX Oncology Holdings | Maintains: Buy | $5 → $2 | $0.42 | +373.60% | 15 | May 9, 2025 | |
| PSNL Personalis | Maintains: Buy | $8 → $9 | $5.04 | +78.57% | 15 | May 7, 2025 | |
| CORT Corcept Therapeutics | Maintains: Buy | $150 → $145 | $70.23 | +106.46% | 22 | May 6, 2025 | |
| EKSO Ekso Bionics Holdings | Maintains: Buy | $9 → $4 | $0.43 | +836.99% | 15 | May 6, 2025 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $1.5 → $7 | $3.37 | +107.72% | 16 | May 2, 2025 | |
| IPHA Innate Pharma | Reiterates: Buy | $12 → $11 | $2.44 | +351.08% | 16 | Apr 24, 2025 | |
| IPA ImmunoPrecise Antibodies | Reiterates: Buy | $5 | $0.45 | +1,013.83% | 11 | Apr 11, 2025 | |
| RNXT RenovoRx | Reiterates: Buy | $3 | $1.06 | +183.02% | 2 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.49 | +839.60% | 12 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.24 | +182.26% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $10.15 | +166.01% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $2.20 | +763.64% | 14 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.34 | - | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $1 | $0.34 | +191.55% | 9 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $17.46 | +43.18% | 18 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.33 | +351.13% | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.75 | +154.55% | 14 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.07 | +367.29% | 8 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $16.86 | +95.73% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $10.35 | +93.24% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $0.16 | +3,711.94% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $4.65 | +437.63% | 13 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $19.61 | +103.98% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.37 | +848.91% | 7 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $14.84 | +61.73% | 12 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $6.67 | +590.17% | 11 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $25.56 | +173.87% | 12 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $69.85 | +57.48% | 3 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $41.72 | +43.82% | 18 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $8.34 | +295.68% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5.5 | $1.26 | +336.51% | 6 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.69 | +1,359.85% | 12 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.82 | +504.40% | 11 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.54 | +827.64% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.11 | - | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.05 | +56.03% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.00 | +900.00% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $2.76 | +226.09% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.81 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.46 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.25 | +620.00% | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.67 | +1,397.01% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.60 | +212.50% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $0.25 | +1,516.81% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $1.89 | +536.47% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.43 | +4,553.33% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $17.07 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $80 | $1.30 | +6,053.85% | 5 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $4.43 | +35.44% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $6.97 | +115.21% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $7.17 | +360.25% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $12.21 | -22.19% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $1.95 | +717,848.72% | 1 | Mar 5, 2020 |
Ocugen
May 12, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $0.67
Upside: +944.78%
Vor Biopharma
May 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.15
Upside: -
ALX Oncology Holdings
May 9, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.42
Upside: +373.60%
Personalis
May 7, 2025
Maintains: Buy
Price Target: $8 → $9
Current: $5.04
Upside: +78.57%
Corcept Therapeutics
May 6, 2025
Maintains: Buy
Price Target: $150 → $145
Current: $70.23
Upside: +106.46%
Ekso Bionics Holdings
May 6, 2025
Maintains: Buy
Price Target: $9 → $4
Current: $0.43
Upside: +836.99%
X4 Pharmaceuticals
May 2, 2025
Maintains: Buy
Price Target: $1.5 → $7
Current: $3.37
Upside: +107.72%
Innate Pharma
Apr 24, 2025
Reiterates: Buy
Price Target: $12 → $11
Current: $2.44
Upside: +351.08%
ImmunoPrecise Antibodies
Apr 11, 2025
Reiterates: Buy
Price Target: $5
Current: $0.45
Upside: +1,013.83%
RenovoRx
Apr 4, 2025
Reiterates: Buy
Price Target: $3
Current: $1.06
Upside: +183.02%
Apr 2, 2025
Reiterates: Buy
Price Target: $14
Current: $1.49
Upside: +839.60%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $1.24
Upside: +182.26%
Apr 1, 2025
Reiterates: Buy
Price Target: $27
Current: $10.15
Upside: +166.01%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $2.20
Upside: +763.64%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.34
Upside: -
Mar 21, 2025
Maintains: Buy
Price Target: $6 → $1
Current: $0.34
Upside: +191.55%
Mar 20, 2025
Reiterates: Buy
Price Target: $25
Current: $17.46
Upside: +43.18%
Mar 20, 2025
Reiterates: Buy
Price Target: $6
Current: $1.33
Upside: +351.13%
Mar 19, 2025
Reiterates: Buy
Price Target: $7
Current: $2.75
Upside: +154.55%
Mar 19, 2025
Reiterates: Buy
Price Target: $5
Current: $1.07
Upside: +367.29%
Mar 19, 2025
Reiterates: Buy
Price Target: $33
Current: $16.86
Upside: +95.73%
Mar 17, 2025
Initiates: Buy
Price Target: $20
Current: $10.35
Upside: +93.24%
Mar 14, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $0.16
Upside: +3,711.94%
Mar 13, 2025
Reiterates: Buy
Price Target: $25
Current: $4.65
Upside: +437.63%
Mar 12, 2025
Reiterates: Buy
Price Target: $40
Current: $19.61
Upside: +103.98%
Mar 11, 2025
Reiterates: Buy
Price Target: $13
Current: $1.37
Upside: +848.91%
Mar 7, 2025
Maintains: Buy
Price Target: $22 → $24
Current: $14.84
Upside: +61.73%
Mar 6, 2025
Reiterates: Buy
Price Target: $46
Current: $6.67
Upside: +590.17%
Mar 3, 2025
Reiterates: Buy
Price Target: $70
Current: $25.56
Upside: +173.87%
Mar 3, 2025
Reiterates: Buy
Price Target: $110
Current: $69.85
Upside: +57.48%
Feb 28, 2025
Reiterates: Buy
Price Target: $60
Current: $41.72
Upside: +43.82%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $8.34
Upside: +295.68%
Jan 14, 2025
Reiterates: Buy
Price Target: $5.5
Current: $1.26
Upside: +336.51%
Dec 10, 2024
Reiterates: Buy
Price Target: $10
Current: $0.69
Upside: +1,359.85%
Nov 29, 2024
Reiterates: Buy
Price Target: $11
Current: $1.82
Upside: +504.40%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $0.54
Upside: +827.64%
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.11
Upside: -
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $7.05
Upside: +56.03%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $2.00
Upside: +900.00%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $2.76
Upside: +226.09%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.81
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.46
Upside: -
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $1.25
Upside: +620.00%
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.67
Upside: +1,397.01%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $1.60
Upside: +212.50%
Nov 4, 2022
Maintains: Buy
Price Target: $3 → $4
Current: $0.25
Upside: +1,516.81%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $1.89
Upside: +536.47%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.43
Upside: +4,553.33%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $17.07
Upside: -
Feb 17, 2022
Maintains: Buy
Price Target: $150 → $80
Current: $1.30
Upside: +6,053.85%
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $4.43
Upside: +35.44%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $6.97
Upside: +115.21%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $7.17
Upside: +360.25%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $12.21
Upside: -22.19%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $1.95
Upside: +717,848.72%